[Studies concerning the antibacterial spectrum of cephalexin monohydrate].
D000818:Animals; D002415:Cats; D002511:Cephalosporins / Q000627:therapeutic use* / Q000633:toxicity; D004285:Dogs; D004754:Enterobacter / Q000187:drug effects; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D004927:Escherichia coli Infections / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D006801:Humans; D005779:Immunodiffusion; D007710:Klebsiella Infections / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D011512:Proteus Infections / Q000188:drug therapy; D051381:Rats; D012480:Salmonella Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy
D002511:Cephalosporins
Estudios sobre el espectro antibacteriano del monohidrato de cefalexina.